French Parliament Investigates HPV Vaccination Campaigns

A three hour debate in Paris concerning the safety, efficacy and necessity of HPV vaccines in French cervical cancer prevention programs was presented to the French Parliament, French Senate, health authorities, medical professionals and the public in May. This discussion was the first time a western government has called experts to testify about the adverse reactions to vaccines.

The debate was spurred by an open letter to the French Minister of Health calling for investigative action towards various aspects of HPV vaccination campaigns. The letter was signed by more than 200 medical professionals, confirming their agreement about safety concerns regarding the vaccines.

CMSRI funded researchers from around the world were in attendance at the debate to weigh in on this hot topic. They shed light on various issues to the discussion board about aluminum adjuvants and human papillomavirus, also known as HPV.

A member of the European Parliament opened the meeting with a speech that stated research findings and the actions necessary to protect the public health. Michele Rivasi opened with – Vaccines are unnecessary, dangerous to many and certainly a huge drain on public health funds.

Rivasi mentioned CMSRI advisory board members and funded researchers during her opening speech by highlighting the findings from Christopher Shaw, Lucija Tomljenovic, Stephanie Seneff, Yeduda Shoenfeld, Chris Exley, and Romain Gherardi – blaming the toxicity of aluminum salts used as adjuvants in vaccines cause adverse reactions.

The injection of aluminum salts could be the source of the unexplained “increase in the number of pathologies reported because they migrate through the body until they reach and accumulate in the brain.  In certain predisposed individuals, very serious adverse effects have been observed following vaccination: death, convulsions, fainting, autistic disorders, Guillain-Barre syndrome, transverse myelitis, facial paralysis, chronic fatigue syndrome, autoimmune diseases, pulmonary embolisms, macrophagic myofasciitis, pancreatitis and others.”

After Rivasi continued with other statements, she urged the need of extensive research before the parliament continues to vaccinate. Finishing with – research before consent, you can’t unvaccinate.

The discussion led to four round tables where CMSRI researchers presented their findings to the French Parliament and others, making the open forum history. The open conversation in Paris is paving the way for other countries to examine the risks vaccines pose on health.